Funds holding REVOLUTION MEDICINES INC WTS 12/26
ISIN US76155X1182 · United States · LEI 549300JU3X0LBCQ65892
- Fund holders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 4.9M $
This issuer has other securities: REVOLUTION MEDICINES INC (US76155X1000)
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 302,672 | 2.8M $ | 0.02 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 198,505 | 1.9M $ | 0.02 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 11,096 | 104.3K $ | 0.01 % | as of Jun 30, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 4,502 | 42.3K $ | 0.02 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 0.02 % | as of Jun 30, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 0.02 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 0.02 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 0.01 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 4 | 0 | 516,775 | 0.0 % |
| 2026Q2 | 4 | 0 | 516,775 | 0.0 % |
| 2026Q1 | 4 | 0 | 516,775 | 0.0 % |
| 2025Q4 | 4 | -1 | 516,775 | -0.4 % |
| 2025Q3 | 5 | -1 | 518,975 | -1.2 % |
| 2025Q2 | 6 | +1 | 525,499 | +0.4 % |
| 2025Q1 | 5 | -1 | 523,299 | -0.4 % |
| 2024Q4 | 6 | 0 | 525,499 | 0.0 % |
| 2024Q3 | 6 | 0 | 525,499 | 0.0 % |
| 2024Q2 | 6 | +1 | 525,499 | +1.1 % |
| 2024Q1 | 5 | 519,540 |
Institutional managers
22 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| LMR Partners LLP | 3,838,024 | 6.9M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 1,580,345 | 2.7M $ | as of Mar 31, 2026 |
| Sculptor Capital LP | 958,822 | 1.7M $ | as of Mar 31, 2026 |
| ARISTEIA CAPITAL, L.L.C. | 583,615 | 1M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 579,550 | 1K $ | as of Mar 31, 2026 |
| Caption Management, LLC | 517,685 | 926.7K $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 500,000 | 895K $ | as of Mar 31, 2026 |
| Lunate Capital Ltd | 450,000 | 805.5K $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 250,000 | 447.5K $ | as of Mar 31, 2026 |
| Bleichroeder LP | 200,000 | 358K $ | as of Mar 31, 2026 |
| WOLVERINE ASSET MANAGEMENT LLC | 170,698 | 305.5K $ | as of Mar 31, 2026 |
| Davidson Kempner Capital Management LP | 150,000 | 261K $ | as of Mar 31, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | 120,085 | 208.9K $ | as of Mar 31, 2026 |
| Weiss Asset Management LP | 73,640 | 128.1K $ | as of Mar 31, 2026 |
| TD Asset Management Inc | 40,636 | 70.7K $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 20,000 | 34.8K $ | as of Mar 31, 2026 |
| CSS LLC/IL | 17,505 | 281.8K $ | as of Mar 31, 2026 |
| TORONTO DOMINION BANK | 10,000 | 17.9K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2,216 | 4K $ | as of Mar 31, 2026 |
| UBS Group AG | 886 | 1.6K $ | as of Mar 31, 2026 |
| TD Waterhouse Canada Inc. | 448 | 790 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 90 | 161 $ | as of Mar 31, 2026 |
Funds holding the debt of REVOLUTION MEDICINES INC WTS 12/26
26 funds declare 26 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Funds holding REVOLUTION MEDICINES INC WTS 12/26". https://titelia.com/en/stocks/revolution-medicines-inc-wts-12-26-US76155X1182